Bausch + Lomb Corporation operates as an eye health company worldwide. It operates through three segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care/Consumer Health Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lens care products, over-the-counter eye drops, eye vitamins, and mineral supplements that address various conditions comprising eye allergies, conjunctivitis, and dry eye. The Ophthalmic Pharmaceuticals segment offers proprietary and generic pharmaceutical products for post-operative treatments, as well as for the treatment of eye conditions, such as glaucoma, ocular hypertension, and retinal diseases; and contact lenses for therapeutic use. The Surgical segment provides tools and technologies for the treatment of cataracts, and vitreous and retinal eye conditions; and intraocular lenses and delivery systems, phacoemulsification equipment, and other surgical instruments and devices. The company was founded in 1853 and is headquartered in Vaughan, Canada.
The current price of BLCO is $16.49 USD — it has decreased by -1.14% in the past 24 hours. Watch Bausch + Lomb stock price performance more closely on the chart.
What is Bausch + Lomb stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Bausch + Lomb stocks are traded under the ticker BLCO.
Is Bausch + Lomb stock price growing?▼
BLCO stock has risen by +7.29% compared to the previous week, the month change is a -8.29% fall, over the last year Bausch + Lomb has showed a +26.94% increase.
What is Bausch + Lomb market cap?▼
Today Bausch + Lomb has the market capitalization of 5.84B
When is the next Bausch + Lomb earnings date?▼
Bausch + Lomb is going to release the next earnings report on May 06, 2026.
What were Bausch + Lomb earnings last quarter?▼
BLCO earnings for the last quarter are 0.32 USD per share, whereas the estimation was 0.36 USD resulting in a -9.9% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Bausch + Lomb revenue for the last year?▼
Bausch + Lomb revenue for the last year amounts to 10.2B USD.
What is Bausch + Lomb net income for the last year?▼
BLCO net income for the last year is -720M USD.
How many employees does Bausch + Lomb have?▼
As of April 03, 2026, the company has 13,500 employees.
In which sector is Bausch + Lomb located?▼
Bausch + Lomb operates in the Health Care sector.
When did Bausch + Lomb complete a stock split?▼
Bausch + Lomb has not had any recent stock splits.